Rezolute Stock Today
| RZLT Stock | USD 3.60 0.14 3.74% |
PerformanceVery Weak
| Odds Of DistressLow
|
Rezolute is selling for under 3.60 as of the 16th of March 2025; that is 3.74 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 3.53. Rezolute has about a 23 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 16th of December 2024 and ending today, the 16th of March 2025. Click here to learn more.
Rezolute, Inc., a clinical stage biopharmaceutical company, develops therapies for metabolic diseases associated with chronic glucose imbalance in the United States. Rezolute, Inc. was incorporated in 2010 and is headquartered in Redwood City, California. The company has 60.54 M outstanding shares of which 1.81 M shares are at this time shorted by private and institutional investors with about 5.38 trading days to cover. More on Rezolute
Moving against Rezolute Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Rezolute Stock Highlights
| CEO, Founder | Nevan JD |
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
| Financial Strength | |
Rezolute (RZLT) is traded on NASDAQ Exchange in USA. It is located in 275 Shoreline Drive, Redwood City, CA, United States, 94065 and employs 64 people. Rezolute is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 217.93 M. Rezolute conducts business under Biotechnology sector and is part of Health Care industry. The entity has 60.54 M outstanding shares of which 1.81 M shares are at this time shorted by private and institutional investors with about 5.38 trading days to cover.
Rezolute currently holds about 150.41 M in cash with (57.37 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.87, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Rezolute Probability Of Bankruptcy
Ownership AllocationRezolute owns a total of 60.54 Million outstanding shares. The majority of Rezolute outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Rezolute to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Rezolute. Please pay attention to any change in the institutional holdings of Rezolute as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Rezolute Ownership Details
Rezolute Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Rezolute market risk premium is the additional return an investor will receive from holding Rezolute long position in a well-diversified portfolio.
| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.22) | |||
| Total Risk Alpha | 0.2282 | |||
| Treynor Ratio | (0.48) |
Rezolute Stock Against Markets
Rezolute Corporate Management
| Raj MD | VP Development | Profile | |
| Michael Deperro | Senior Development | Profile | |
| LLM JD | Chief Officer | Profile | |
| Gopal MBBS | Senior Development | Profile | |
| MD MBA | Director Affairs | Profile | |
| Daron Evans | Chief Officer | Profile | |
| Erin OBoyle | Senior Operations | Profile |
Additional Tools for Rezolute Stock Analysis
When running Rezolute's price analysis, check to measure Rezolute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rezolute is operating at the current time. Most of Rezolute's value examination focuses on studying past and present price action to predict the probability of Rezolute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rezolute's price. Additionally, you may evaluate how the addition of Rezolute to your portfolios can decrease your overall portfolio volatility.